Lisata Therapeutics (FRA:8NE) FFO


FRA:8NE Lisata Therapeutics Inc FRA:8NE
32 GF Score
Price €2.74
! 4 Warning Signs
View Full Analysis

What is Lisata Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:8NE
32GF Score
Lisata Therapeutics Inc FRA:8NE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lisata Therapeutics Business Description

Other Exchanges LSTA:USA0HS8:UK
Address 110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
32GF Score

Get the complete analysis for FRA:8NE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price